4581 — Taisho Pharmaceutical Holdings Co Share News
0.000.00%
- ¥704bn
- ¥463bn
- ¥301bn
Japan's Takeda plans to sell consumer health unit for around $3.7 bln - Nikkei (updated)
Japan's Takeda plans to sell consumer health unit for around $3.7 bln - Nikkei
Table: Taisho Pharmaceutical HD - 9-MTH group results
Table: Taisho Pharmaceutical HD -2019/20 group forecast
Table: Taisho Pharmaceutical HD - 6-MTH group results
Brief: Moberg Pharma And Taisho Sign Exclusive License Agreement For Mob-015 In Japan
2019 6-month group forecast
Table: Taisho Pharmaceutical HD -2019/20 group forecast
Table: Taisho Pharmaceutical HD -Q1 group results
Brief: Taisho Pharmaceutical Completes Procedures For Acquisition Of UPSA SAS
To Cancel Treasury Shares Worth 5.55% Of Outstanding Stock On June 14
Table: Taisho Pharmaceutical HD -2018/19 group results
Table: Taisho Pharmaceutical HD -2018/19 parent results
Table: Taisho Pharmaceutical HD - 9-MTH group results
Bristol-Myers gets $1.6 bln offer for French consumer health unit (updated)
Bristol-Myers gets $1.6 bln offer for French consumer health unit
Brief: Bristol-Myers Squibb Announces Offer From Taisho Pharmaceutical To Purchase UPSA
Brief: Taisho Pharmaceutical Holdings: To Buy UPSA For $1.6 Billion From Bristol-Myers
Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg (updated)